Advancing Healthcare Through Innovation

Empowering clinicians with Next-Generation Sequencing (NGS) for precise diagnosis and enhanced patient outcomes. Committed to accessibility, affordability, and excellence in onco-haematological care.

Why Choose
Us?

Cutting-Edge Testing

Advanced NGS technology for precise diagnostics.

Trusted Partnerships

Collaborating with leading institutions worldwide.

Affordable Solutions

Innovative pricing for cost-effective testing.

About Us

Revolutionising Healthcare Through Innovation.

At Haemogene, we are dedicated to revolutionising haematology diagnostics by making Next-Generation Sequencing (NGS) testing both accessible and affordable. Our mission is to close the gap in genetic testing availability, ensuring that every patient—regardless of location or financial circumstances—receives accurate, timely, and life-saving diagnostics.

Through strategic partnerships with University College London (UCL), HSL Laboratories, and global healthcare providers, we deliver cutting-edge genetic testing to the Middle East and beyond.

Our Services

Haemogene provides state-of-the-art genomic testing, including NGS, RNA sequencing, and molecular panels for precise diagnostics. We also offer consultancy, laboratory advocacy, and training services to support and empower healthcare professionals globally.
Haemogene, in collaboration with University College London (UCL) and Health Service Laboratories (HSL), provides advanced genetic testing for precise diagnostics. Our services cover cancer genomics, inherited disorders, and rare genetic conditions, offering reliable insights for clinicians and researchers.

Using Next-Generation Sequencing (NGS) technology, we enable detailed genetic profiling that supports early diagnosis, personalised treatment, and improved patient care. Our commitment to excellence ensures healthcare professionals receive high-quality genomic data for informed clinical decisions.
Haemogene’s Remote Test Reporting service enhances diagnostic accessibility by delivering fast, accurate, and expert-validated results, regardless of location. In partnership with University College London (UCL) and Health Service Laboratories (HSL), we provide seamless remote interpretation of genetic and hematology tests, ensuring timely, actionable insights for clinicians.

Our secure digital infrastructure allows specialist hematologists to remotely analyse and validate results, supporting efficient clinical decision-making and improving diagnostic precision. This service makes advanced testing accessible globally, minimising delays in patient management.
Haemogene provides expert consultancy services in hematology, led by Professor Rajeev Gupta and a team of specialists. We offer comprehensive support in interpreting complex hematology and genetic test results, ensuring clinicians receive precise, actionable insights for patient management.

Specialising in Next-Generation Sequencing (NGS) data analysis, molecular diagnostics, and personalised treatment strategies, we help healthcare professionals optimise diagnostic accuracy and clinical decisions. From case reviews to protocol optimisation and expert second opinions, Haemogene’s consultancy services empower clinicians and laboratories worldwide to deliver outstanding patient care.
Haemogene is dedicated to optimising laboratory use and ensuring cost-effective healthcare through expert advocacy services. We collaborate with clinicians, laboratories, and healthcare institutions to guide the selection of the most clinically relevant diagnostic tests, ensuring accurate diagnoses and maximising resource efficiency.

In resource-limited regions, we help identify high-value testing strategies that provide actionable insights for patient care. By streamlining laboratory workflows, reducing unnecessary tests, and improving diagnostic precision, Haemogene ensures laboratories operate efficiently while upholding the highest standards of patient care.
Haemogene offers comprehensive training programmes for laboratory staff and clinicians, ensuring expertise in advanced hematology and genetic testing techniques. Our tailored training covers Next-Generation Sequencing (NGS), molecular diagnostics, and best laboratory practices, providing professionals with up-to-date industry knowledge.

We deliver hands-on training at our state-of-the-art HSL laboratories and on-site visits to partner labs for protocol optimisation and quality assurance. Our expert-led seminars and workshops also help clinicians interpret complex hematology diagnostics, ultimately improving patient outcomes. Through our commitment to education and skill development, Haemogene empowers healthcare professionals to excel in precision medicine and diagnostics.

Latest Blogs & Insights

FAQ

Frequently Asked Questions

If you have more questions, feel free to reach out to us!

What is Next-Generation Sequencing (NGS)?

NGS is an advanced genetic testing technology that enables rapid and comprehensive analysis of DNA and RNA. It plays a crucial role in diagnosing genetic disorders, guiding cancer treatments, and identifying inherited conditions with exceptional accuracy.
Genetic testing is valuable for patients with suspected hereditary conditions, cancer patients, individuals with rare diseases, and those seeking personalised treatment plans. Healthcare providers also use genetic insights to make informed decisions.

The process includes:

  • Sample Collection – A blood or tissue sample is taken from the patient.
  • Laboratory Analysis – The sample is processed using NGS technology.
  • Data Interpretation – Experts analyse genetic variations and provide a detailed report.
  • Clinical Consultation – The results are shared with the patient’s physician for treatment planning.
All testing is conducted in collaboration with Health Service Laboratories (HSL) and University College London (UCL), ensuring the highest standards of accuracy and reliability.
Turnaround times vary depending on the test type, but most NGS tests provide results within 2 to 4 weeks. Urgent cases can be expedited.
Coverage varies depending on location and insurance providers. We collaborate with healthcare systems and insurers to make testing as affordable as possible. Contact us for further details on coverage options.
Yes, we collaborate with international healthcare providers, hospitals, and health ministries to receive and analyse samples from different countries, ensuring global access to genetic testing.

NGS is used for various medical applications, including:

  • Cancer Genomics (Leukaemia, Lymphoma, Solid Tumours)
  • Hereditary Disorders
  • Rare Genetic Conditions
  • Pharmacogenomics (Personalised Drug Response)
  • Minimal Residual Disease (MRD) Monitoring
Absolutely. We adhere to strict data security protocols and comply with international privacy regulations (GDPR, HIPAA) to ensure your information remains confidential and protected.
You can speak with your healthcare provider or contact us directly to learn about test options and procedures. We’ll guide you through the process and connect you with the appropriate service.